Veracyte (VCYT) Tops Q4 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
- Vertiv shares fall on analyst downgrades and options bets
- Most Asian stocks rise as calm returns after CoreWeave shock; Indonesia faces market downgrade
- S&P 500 ends higher as traders shift from AI to healthcare
- Rocket Lab USA (RKLB) Reiterated at Overweight by Cantor Fitzgerald as Neutron Launch Moved to Next Year
- Caterpillar names Derrick York to lead Resource Industries
Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook
March 1, 2017 4:05 PM ESTSOUTH SAN FRANCISCO, Calif., March 1, 2017 /PRNewswire/ --
Revenue Grew 31%, to $65.1 Million in 2016
Full-Year Afirma® GEC Volume Increased 20%, to 23,237 Tests
Conference Call and Webcast Today at 4:30 p.m. ET
Veracyte, Inc. (NASDAQ: VCYT) today announced financial results and business progress for the quarter and full year ended December 31, 2016, and provided financial guidance for 2017.
"We delivered strong revenue growth and executed on the key... More



